PRNewsWire
15 Oct 2026, 06:04 UTC · 1h ago
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
Impact · against what's priced in
The appointment of Dr. Joanna Holbrook as CSO is a positive development for Evotec, bringing high-tier pharma leadership from Novo Nordisk to enhance AI-driven discovery and strategic partnerships. While personnel changes are often viewed as marginal, the specific overlap of AI and big-pharma experience provides a tangible catalyst for future partnership win rates.
- EVO+0.30
No priced-in read yet





